Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SUNS
4226
Sunrise Realty Trust
SUNS
$83.8M
| $209K | ﹤0.01% |
22,183
+1,518
| +7% | +$14.9K |
2024 Q3
5 quarters
|
|
4227
LifeMD
LFMD
$132M
| $208K | ﹤0.01% |
61,028
+7,300
| +14% | +$35.4K |
2023 Q3
9 quarters
|
|
4228
Omega Flex
OFLX
$266M
| $208K | ﹤0.01% |
7,060
+882
| +14% | +$25.2K |
2019 Q1
27 quarters
|
|
4229
ECB Bancorp
ECBK
$179M
| $207K | ﹤0.01% |
11,921
+1,076
| +10% | +$17.9K |
2024 Q3
5 quarters
|
|
4230
Amplify Energy
AMPY
$181M
| $207K | ﹤0.01% |
+45,298
| New | +$225K |
2025 Q4
0 quarters
|
|
4231
Senseonics Holdings Inc
SENS
$522M
| $207K | ﹤0.01% |
+37,500
| New | +$261K |
2025 Q4
0 quarters
|
|
4232
Taylor Devices
TAYD
$177M
| $207K | ﹤0.01% |
3,533
+3,043
| +621% | +$148K |
2024 Q2
6 quarters
|
|
|
FINV
4233
FinVolution Group
FINV
$685M
| $206K | ﹤0.01% |
39,416
+33,919
| +617% | +$199K |
2022 Q2
14 quarters
|
|
4234
Duos Technologies
DUOT
$287M
| $205K | ﹤0.01% |
18,241
+16,455
| +921% | +$154K |
2025 Q3
1 quarter
|
|
|
ACR
4235
ACRES Commercial Realty
ACR
$171M
| $205K | ﹤0.01% |
9,610
+939
| +11% | +$20K |
2022 Q1
15 quarters
|
|
4236
Greenwich LifeSciences
GLSI
$249M
| $205K | ﹤0.01% |
9,744
+1,030
| +12% | +$10.8K |
2024 Q2
6 quarters
|
|
|
NOAH
4237
Noah Holdings
NOAH
$535M
| $204K | ﹤0.01% |
20,306
-13,042
| -39% | -$142K |
2018 Q2
30 quarters
|
|
4238
M-tron Industries
MPTI
$335M
| $204K | ﹤0.01% |
3,830
+317
| +9% | +$16.7K |
2024 Q3
5 quarters
|
|
4239
Expensify
EXFY
$205M
| $203K | ﹤0.01% |
134,689
+9,080
| +7% | +$14.4K |
2023 Q1
11 quarters
|
|
4240
Protalix BioTherapeutics
PLX
$218M
| $203K | ﹤0.01% |
112,849
+11,051
| +11% | +$22.6K |
2022 Q1
15 quarters
|
|
4241
Union Bankshares
UNB
$114M
| $203K | ﹤0.01% |
8,542
+2,548
| +43% | +$60K |
2024 Q3
5 quarters
|
|
4242
Grayscale Bitcoin Trust
GBTC
$12.6B
| $202K | ﹤0.01% |
+2,950
| New | +$231K |
2025 Q4
0 quarters
|
|
|
COE
4243
51Talk Online Education Group
COE
$63.6M
| $201K | ﹤0.01% |
6,308
| – | – |
2025 Q2
2 quarters
|
|
4244
Zevia
ZVIA
$87.3M
| $201K | ﹤0.01% |
86,775
+33,473
| +63% | +$83.1K |
2025 Q2
2 quarters
|
|
4245
Innovator US Equity Power Buffer ETF August
PAUG
$1.05B
| $201K | ﹤0.01% |
+4,653
| New | +$199K |
2025 Q4
0 quarters
|
|
4246
FT Vest US Equity Buffer & Premium Income ETF March
XIMR
$26.6M
| $201K | ﹤0.01% |
6,452
+46
| +0.7% | +$1.43K |
2024 Q3
5 quarters
|
|
4247
Inseego
INSG
$81.1M
| $201K | ﹤0.01% |
19,593
+2,080
| +12% | +$27K |
2017 Q4
32 quarters
|
|
4248
FT Vest US Equity Moderate Buffer ETF March
GMAR
$424M
| $200K | ﹤0.01% |
4,895
-104
| -2% | -$4.2K |
2025 Q2
2 quarters
|
|
4249
Townsquare Media
TSQ
$83M
| $200K | ﹤0.01% |
38,955
-2,013
| -5% | -$11.3K |
2020 Q2
22 quarters
|
|
4250
FT Vest US Equity Deep Buffer ETF February
DFEB
$449M
| $200K | ﹤0.01% |
4,195
-117
| -3% | -$5.5K |
2024 Q3
5 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.